Nanotherapeutics in Kidney Disease: Innovations, Challenges, and Future Directions.
Ontology highlight
ABSTRACT: The treatment and management of kidney diseases present a significant global challenge, affecting over 800 million individuals and necessitating innovative therapeutic strategies that transcend symptomatic relief. The application of nanotechnology to therapies for kidney diseases, while still in its early stages, holds transformative potential for improving treatment outcomes. Recent advancements in nanoparticle-based drug delivery leverage the unique physicochemical properties of nanoparticles for targeted and controlled therapeutic delivery to the kidneys. Current research is focused on understanding the functional and phenotypic changes in kidney cells during both acute and chronic conditions, allowing for the identification of optimal target cells. In addition, the development of tailo
SUBMITTER: Roointan A
PROVIDER: S-EPMC11888965 | biostudies-literature | 2025 Mar
REPOSITORIES: biostudies-literature
ACCESS DATA